[go: up one dir, main page]

GB9508823D0 - Drug Derivatives - Google Patents

Drug Derivatives

Info

Publication number
GB9508823D0
GB9508823D0 GBGB9508823.3A GB9508823A GB9508823D0 GB 9508823 D0 GB9508823 D0 GB 9508823D0 GB 9508823 A GB9508823 A GB 9508823A GB 9508823 D0 GB9508823 D0 GB 9508823D0
Authority
GB
United Kingdom
Prior art keywords
drug derivatives
drug
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9508823.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Priority to GBGB9508823.3A priority Critical patent/GB9508823D0/en
Publication of GB9508823D0 publication Critical patent/GB9508823D0/en
Priority to UA97115654A priority patent/UA61884C2/en
Priority to ZA963360A priority patent/ZA963360B/en
Priority to MYPI96001594A priority patent/MY118354A/en
Priority to IL11806196A priority patent/IL118061A/en
Priority to ZA963397A priority patent/ZA963397B/en
Priority to ARP960102410A priority patent/AR004483A1/en
Priority to MYPI96001647A priority patent/MY117596A/en
Priority to ZA963433A priority patent/ZA963433B/en
Priority to KR1019970707770A priority patent/KR19990008244A/en
Priority to DE69633008T priority patent/DE69633008T2/en
Priority to EP96912139A priority patent/EP0823889B1/en
Priority to AT96912139T priority patent/ATE224353T1/en
Priority to TR97/01276T priority patent/TR199701276T1/en
Priority to EE9700275A priority patent/EE04462B1/en
Priority to AU55079/96A priority patent/AU713858B2/en
Priority to SI9630542T priority patent/SI0823889T1/en
Priority to DE69623764T priority patent/DE69623764T2/en
Priority to ES96912139T priority patent/ES2185772T3/en
Priority to JP53312196A priority patent/JP4213205B2/en
Priority to CA002218702A priority patent/CA2218702C/en
Priority to CZ973413A priority patent/CZ341397A3/en
Priority to SK1470-97A priority patent/SK147097A3/en
Priority to CZ0341497A priority patent/CZ297646B6/en
Priority to US12/230,018 priority patent/USRE43632E1/en
Priority to HU9802308A priority patent/HUP9802308A3/en
Priority to PCT/GB1996/001054 priority patent/WO1996034858A1/en
Priority to AT96912140T priority patent/ATE272055T1/en
Priority to PT96912139T priority patent/PT823889E/en
Priority to KR1019970707769A priority patent/KR19990008243A/en
Priority to JP53312096A priority patent/JP3960481B2/en
Priority to ES96912138T priority patent/ES2224166T3/en
Priority to CA002218699A priority patent/CA2218699C/en
Priority to RU97119631/04A priority patent/RU2215733C2/en
Priority to US11/405,041 priority patent/USRE40480E1/en
Priority to AU55080/96A priority patent/AU707600B2/en
Priority to CA2220091A priority patent/CA2220091C/en
Priority to US08/952,305 priority patent/US6015821A/en
Priority to SI9630690T priority patent/SI0823895T1/en
Priority to PCT/GB1996/001053 priority patent/WO1996034846A1/en
Priority to JP53312296A priority patent/JP4553166B2/en
Priority to DE69633009T priority patent/DE69633009T2/en
Priority to DK96912139T priority patent/DK0823889T3/en
Priority to DK96912140T priority patent/DK0823897T3/en
Priority to BR9606604A priority patent/BR9606604A/en
Priority to AU55081/96A priority patent/AU713045B2/en
Priority to EP96912140A priority patent/EP0823897B1/en
Priority to EP96912138A priority patent/EP0823895B1/en
Priority to ES96912140T priority patent/ES2225879T3/en
Priority to KR1019970707768A priority patent/KR19990008242A/en
Priority to NZ306509A priority patent/NZ306509A/en
Priority to EE9700281A priority patent/EE9700281A/en
Priority to SK1469-97A priority patent/SK285135B6/en
Priority to DK96912138T priority patent/DK0823895T3/en
Priority to TR97/01277T priority patent/TR199701277T1/en
Priority to BR9606607A priority patent/BR9606607A/en
Priority to AT96912138T priority patent/ATE272053T1/en
Priority to NZ306510A priority patent/NZ306510A/en
Priority to PT96912140T priority patent/PT823897E/en
Priority to PL96323176A priority patent/PL323176A1/en
Priority to PT96912138T priority patent/PT823895E/en
Priority to PCT/GB1996/001052 priority patent/WO1996034855A1/en
Priority to HU9802384A priority patent/HUP9802384A3/en
Priority to US08/945,667 priority patent/US6555700B1/en
Priority to CNB961950625A priority patent/CN100391930C/en
Priority to JO19961930A priority patent/JO1930B1/en
Priority to PL96323152A priority patent/PL187172B1/en
Priority to NZ306508A priority patent/NZ306508A/en
Priority to IS4603A priority patent/IS4603A/en
Priority to IS4604A priority patent/IS4604A/en
Priority to NO975036A priority patent/NO975036L/en
Priority to BG102011A priority patent/BG63892B1/en
Priority to NO975035A priority patent/NO975035L/en
Priority to BG102012A priority patent/BG102012A/en
Priority to HK98103042A priority patent/HK1003882A1/en
Priority to US09/376,617 priority patent/US6245811B1/en
Priority to JP2007097560A priority patent/JP2007231020A/en
Pending legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB9508823.3A 1995-05-01 1995-05-01 Drug Derivatives Pending GB9508823D0 (en)

Priority Applications (77)

Application Number Priority Date Filing Date Title
GBGB9508823.3A GB9508823D0 (en) 1995-05-01 1995-05-01 Drug Derivatives
UA97115654A UA61884C2 (en) 1995-05-01 1996-01-05 1,3-propane diol derivatives as biologically active compounds
ZA963360A ZA963360B (en) 1995-05-01 1996-04-26 Presentation of bioactives
MYPI96001594A MY118354A (en) 1995-05-01 1996-04-26 1,3-propane diol derivatives as bioactive compounds
IL11806196A IL118061A (en) 1995-05-01 1996-04-29 1,3-propanediol diesters for use in therapy and some novel such diesters
ZA963397A ZA963397B (en) 1995-05-01 1996-04-29 Esters and pharmaceutical compositions
ARP960102410A AR004483A1 (en) 1995-05-01 1996-04-30 COMPOUNDS FOR THERAPY USE INCLUDING A 1,3-PROPANE DIOL WASTE AS A BINDING AGENT BETWEEN FATTY ACID WASTE AND A BIOACTIVE WASTE, USES OF THESE COMPOUNDS AND MEDICINES, FOODS AND TREATMENT AND TREATMENT TO SUCH COMPOUNDS
MYPI96001647A MY117596A (en) 1995-05-01 1996-04-30 Fatty acid esters as bioactive compounds
ZA963433A ZA963433B (en) 1995-05-01 1996-04-30 Presentation of bioactives
KR1019970707770A KR19990008244A (en) 1995-05-01 1996-05-01 1,3-propanediol derivatives as bioactive compounds
DE69633008T DE69633008T2 (en) 1995-05-01 1996-05-01 Fatty acid esters as organic compounds
EP96912139A EP0823889B1 (en) 1995-05-01 1996-05-01 1,3-propane diol derivatives as bioactive compounds
AT96912139T ATE224353T1 (en) 1995-05-01 1996-05-01 1,3-PROPANEDIOL DERIVATIVES AS BIOACTIVE COMPOUNDS
TR97/01276T TR199701276T1 (en) 1995-05-01 1996-05-01 1,3-propane diol derivatives as bioactive compounds.
EE9700275A EE04462B1 (en) 1995-05-01 1996-05-01 1,3-propanediol derivatives as bioactive compounds
AU55079/96A AU713858B2 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
SI9630542T SI0823889T1 (en) 1995-05-01 1996-05-01 1,3-propane diol derivatives as bioactive compounds
DE69623764T DE69623764T2 (en) 1995-05-01 1996-05-01 1,3-PROPANDIOL DERIVATIVES AS BIOACTIVE COMPOUNDS
ES96912139T ES2185772T3 (en) 1995-05-01 1996-05-01 DERIVATIVES OF 1,3-PROPANE-DIOL AS BIOACTIVE COMPOUNDS.
JP53312196A JP4213205B2 (en) 1995-05-01 1996-05-01 1,3-propanediol derivatives as biologically active compounds
CA002218702A CA2218702C (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
CZ973413A CZ341397A3 (en) 1995-05-01 1996-05-01 Esters of fatty acids as biologically active compounds
SK1470-97A SK147097A3 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
CZ0341497A CZ297646B6 (en) 1995-05-01 1996-05-01 Compounds of 1,3-propane diol linked structure, pharmaceutical, nutritional and cosmetic composition containing thereof as well as use of these compounds
US12/230,018 USRE43632E1 (en) 1995-05-01 1996-05-01 1,3-propane diol esters and ethers and methods for their use in drug delivery
HU9802308A HUP9802308A3 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds and process for preparing pharmaceutical compns. contg. them
PCT/GB1996/001054 WO1996034858A1 (en) 1995-05-01 1996-05-01 Nicotinic acid esters and pharmaceutical compositions containing them
AT96912140T ATE272055T1 (en) 1995-05-01 1996-05-01 NICOTINIC ACID ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
PT96912139T PT823889E (en) 1995-05-01 1996-05-01 1,3-PROPANODIOL DERIVATIVES AS BIOACTIVE COMPOUNDS
KR1019970707769A KR19990008243A (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compound
JP53312096A JP3960481B2 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
ES96912138T ES2224166T3 (en) 1995-05-01 1996-05-01 ESTERES OF FATTY ACIDS AS BIOACTIVE COMPOUNDS.
CA002218699A CA2218699C (en) 1995-05-01 1996-05-01 1,3-propane diol derivatives as bioactive compounds
RU97119631/04A RU2215733C2 (en) 1995-05-01 1996-05-01 Derivatives of 1,3-propanediol and their using as biologically active substances
US11/405,041 USRE40480E1 (en) 1995-05-01 1996-05-01 1,3-Propane diol esters and ethers and methods for their use in drug delivery
AU55080/96A AU707600B2 (en) 1995-05-01 1996-05-01 1,3-propane diol derivatives as bioactive compounds
CA2220091A CA2220091C (en) 1995-05-01 1996-05-01 Nicotinic acid esters and pharmaceutical compositions containing them
US08/952,305 US6015821A (en) 1995-05-01 1996-05-01 Nicotinic acid esters and pharmaceutical compositions containing them
SI9630690T SI0823895T1 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
PCT/GB1996/001053 WO1996034846A1 (en) 1995-05-01 1996-05-01 1,3-propane diol derivatives as bioactive compounds
JP53312296A JP4553166B2 (en) 1995-05-01 1996-05-01 Nicotinic acid ester and pharmaceutical composition containing the same
DE69633009T DE69633009T2 (en) 1995-05-01 1996-05-01 NICOTINIC ACID AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF
DK96912139T DK0823889T3 (en) 1995-05-01 1996-05-01 1,3-propanediol derivatives as bioactive compounds
DK96912140T DK0823897T3 (en) 1995-05-01 1996-05-01 Nicotinic esters and pharmaceutical compositions containing them
BR9606604A BR9606604A (en) 1995-05-01 1996-05-01 Compound and method for the manufacture of a medicine or to improve the transport of a drug or other asset to cross the lipid membranes in the body or ensure action
AU55081/96A AU713045B2 (en) 1995-05-01 1996-05-01 Nicotinic acid esters and pharmaceutical compositions containing them
EP96912140A EP0823897B1 (en) 1995-05-01 1996-05-01 Nicotinic acid esters and pharmaceutical compositions containing them
EP96912138A EP0823895B1 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
ES96912140T ES2225879T3 (en) 1995-05-01 1996-05-01 ESTERES OF NICOTINIC ACID AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
KR1019970707768A KR19990008242A (en) 1995-05-01 1996-05-01 Drugs containing nicotinic acid esters and nicotinic acid esters
NZ306509A NZ306509A (en) 1995-05-01 1996-05-01 1,3-propane diol derivatives as bioactive compounds
EE9700281A EE9700281A (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
SK1469-97A SK285135B6 (en) 1995-05-01 1996-05-01 1,3-Propane diol derivative and its use
DK96912138T DK0823895T3 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
TR97/01277T TR199701277T1 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds.
BR9606607A BR9606607A (en) 1995-05-01 1996-05-01 Compound method of improving the transport of a drug or other active method of making a drug compound using method of treating a disease and method of preparing a drug
AT96912138T ATE272053T1 (en) 1995-05-01 1996-05-01 FATTY ACID ESTERS AS BIOACTIVE COMPOUNDS
NZ306510A NZ306510A (en) 1995-05-01 1996-05-01 Niacin derivatives which include a fatty acid or fatty acid alcohol residue and their use in medicaments and skin care compositions
PT96912140T PT823897E (en) 1995-05-01 1996-05-01 NICOTIC ACID ESTERS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PL96323176A PL323176A1 (en) 1995-05-01 1996-05-01 Esters of fatty acids as biologically active compounds
PT96912138T PT823895E (en) 1995-05-01 1996-05-01 ESTERS OF FATTY ACIDS AS COMPOUND BIOACTIVES
PCT/GB1996/001052 WO1996034855A1 (en) 1995-05-01 1996-05-01 Fatty acid esters as bioactive compounds
HU9802384A HUP9802384A3 (en) 1995-05-01 1996-05-01 1,3-propane diol derivatives as bioactive compounds and their use
US08/945,667 US6555700B1 (en) 1995-05-01 1996-05-01 1,3-propane diol esters and ethers and methods for their use in drug delivery
CNB961950625A CN100391930C (en) 1995-05-01 1996-05-01 1, 3-propane diol derivatives as bioactive compounds
JO19961930A JO1930B1 (en) 1995-05-01 1996-05-02 Presentation of bioactives
PL96323152A PL187172B1 (en) 1995-05-01 1997-10-20 Derivatives of 1,3-propanodiole as biologically active compounds
NZ306508A NZ306508A (en) 1995-05-01 1997-10-20 Fatty acid esters as bioactive compounds
IS4603A IS4603A (en) 1995-05-01 1997-10-30 Esters of fatty acids as bioactive compounds
IS4604A IS4604A (en) 1995-05-01 1997-10-30 1,3-propandiol derivatives as bioactive compounds
NO975036A NO975036L (en) 1995-05-01 1997-10-31 1,3-propanediol derivatives as bioactive compounds
BG102011A BG63892B1 (en) 1995-05-01 1997-10-31 Derivatives of 1,3-propanediol as biologically active compounds
NO975035A NO975035L (en) 1995-05-01 1997-10-31 Fatty acid esters as bioactive compounds
BG102012A BG102012A (en) 1995-05-01 1997-10-31 Fatty acid esters as bioactive compounds
HK98103042A HK1003882A1 (en) 1995-05-01 1998-04-14 1,3-propane diol derivatives as bioactive compounds
US09/376,617 US6245811B1 (en) 1995-05-01 1999-08-18 Fatty acid esters as bioactive compounds
JP2007097560A JP2007231020A (en) 1995-05-01 2007-04-03 1,3-propanediol derivatives as biologically active compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9508823.3A GB9508823D0 (en) 1995-05-01 1995-05-01 Drug Derivatives

Publications (1)

Publication Number Publication Date
GB9508823D0 true GB9508823D0 (en) 1995-06-21

Family

ID=10773801

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9508823.3A Pending GB9508823D0 (en) 1995-05-01 1995-05-01 Drug Derivatives

Country Status (5)

Country Link
CN (1) CN100391930C (en)
GB (1) GB9508823D0 (en)
JO (1) JO1930B1 (en)
UA (1) UA61884C2 (en)
ZA (3) ZA963360B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
CA2255615C (en) * 1996-05-22 2006-08-29 Neuromedica, Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel
EP1037624B1 (en) * 1997-12-12 2005-11-23 Purdue Research Foundation Use of conjugated linoleic acid for treating type ii diabetes
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
US6794375B2 (en) * 2000-01-28 2004-09-21 The Procter & Gamble Co. Palatable arginine compounds and uses thereof for cardiovascular health
US8288369B2 (en) * 2006-06-27 2012-10-16 University Of South Florida Delta-tocotrienol treatment and prevention of pancreatic cancer
CN102260178A (en) * 2010-05-25 2011-11-30 中国医学科学院药物研究所 Hydroxyl propanediol derivative, its preparation method, its pharmaceutical composition and its purpose
CN102260177A (en) * 2010-05-25 2011-11-30 中国医学科学院药物研究所 Propylene glycol derivative, preparation method thereof, pharmaceutical composition thereof and application thereof
EP2844257A4 (en) * 2012-05-01 2016-06-01 Catabasis Pharmaceuticals Inc Fatty acid conjugates of statin and fxr agonists; compositions and method of uses
CN106957307B (en) * 2017-03-27 2019-06-28 淮阴工学院 A kind of dantrolene sodium derivative and preparation method thereof

Also Published As

Publication number Publication date
CN100391930C (en) 2008-06-04
ZA963433B (en) 1996-08-07
ZA963397B (en) 1996-08-07
ZA963360B (en) 1996-08-20
UA61884C2 (en) 2003-12-15
JO1930B1 (en) 1997-01-15
CN1189148A (en) 1998-07-29

Similar Documents

Publication Publication Date Title
GR3032486T3 (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents
NZ305444A (en) 4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en) 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
HUP9800523A3 (en) Insulin derivatives
IL135376A0 (en) Hydroxyalkyl-phenyl derivatives
GB2306473A8 (en) Glucoxide derivatives
ZA969990B (en) Oxymethoxy-3-aryl-pyrone derivatives
ZA96228B (en) Indolepiperidine derivatives
ZA969278B (en) Purin-6-one derivatives
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
HU9600107D0 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
NZ332395A (en) Benzonthiazole derivatives
SI0758644T1 (en) Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
SG60005A1 (en) 1-Fluorocyclohexene-difluorophenyl derivatives
GB9508823D0 (en) Drug Derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
IL123621A0 (en) Diarylalkenylamine derivatives
HK1003299A1 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
ZA964470B (en) Cycloalkane-benzylidene derivatives
IL117858A0 (en) 4-Indolypiperazinyl derivatives
ZA96629B (en) 4-Aminobenzolylguanidine derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
IL123000A0 (en) Aza-anthracyclinone derivatives
ZA967204B (en) Alkenyl-benzoylguanidine derivatives